INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 223 filers reported holding INSMED INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $117,508,000 | +26.8% | 4,653,772 | +6.0% | 0.15% | +39.6% |
Q2 2023 | $92,652,000 | +34.1% | 4,391,080 | +8.4% | 0.11% | +29.3% |
Q1 2023 | $69,093,000 | -5.3% | 4,052,364 | +11.0% | 0.08% | -4.7% |
Q4 2022 | $72,943,000 | -4.9% | 3,650,805 | +2.6% | 0.09% | -8.5% |
Q3 2022 | $76,665,000 | +11.1% | 3,557,924 | +1.7% | 0.09% | +22.1% |
Q2 2022 | $69,000,000 | -13.0% | 3,499,010 | +3.7% | 0.08% | +28.3% |
Q1 2022 | $79,315,000 | -8.4% | 3,375,105 | +6.1% | 0.06% | -16.7% |
Q4 2021 | $86,620,000 | -6.8% | 3,179,883 | -5.8% | 0.07% | -8.9% |
Q3 2021 | $92,954,000 | +2.4% | 3,375,266 | +5.8% | 0.08% | +5.3% |
Q2 2021 | $90,777,000 | +914.9% | 3,189,635 | +1114.6% | 0.08% | +476.9% |
Q1 2021 | $8,944,000 | +5745.8% | 262,617 | +5625.2% | 0.01% | – |
Q4 2020 | $153,000 | +4.1% | 4,587 | 0.0% | 0.00% | – |
Q3 2020 | $147,000 | +16.7% | 4,587 | 0.0% | 0.00% | – |
Q2 2020 | $126,000 | -92.4% | 4,587 | -93.4% | 0.00% | -100.0% |
Q2 2018 | $1,656,000 | – | 70,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |